We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This adapted COVID-19 vaccine targets both the original virus and the Omicron BA.4 and BA.5 sub-variants.
To improve medical product safety for all, report suspected side effects and adverse incidents as part of the #MedSafetyWeek global campaign
Patients using antibiotic Targocid 200mg powder at home must check if the batch number of their medicine is 0J25D1 or 0J25D2. Anyone who has one of these two batches should stop their treatment and seek immediate medical adv…
Significant funding for research centres across the country to support the improved delivery of health and care services and ground-breaking new treatments.
First published during the 2022 Truss Conservative government
Healthcare professionals asked to share their views on how they want to receive safety information from the UK medicines and medical devices regulator
The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have been awarded £1.8m funding by Wellcome over three years to explore and produce guidance on regulating digital mental health tools.
The Secretary of State for Health and Social Care's letter to a group of charities and patients on the decision not to procure Evusheld as a COVID-19 treatment.
European Commission Decision Reliance Procedure (ECDRP) now continues to be available until 31 December 2023.
DEKRA Certification UK Ltd has now joined the three current UK Approved Bodies
The MHRA is introducing a new, single code of practice for all its scientific advisory committees.
Published advice updated to include an additional bivalent vaccine now approved by the Medicines and Healthcare products Regulatory Agency (MHRA).
The adapted COVID-19 vaccine targets both the original virus and the Omicron variant
UKHSA and MHRA are expanding polio sewage surveillance to a range of areas outside of the capital.
Head of the HRT Taskforce Madelaine McTernan presents key recommendations for future management of hormone replacement therapy (HRT) supply.
First published during the 2019 to 2022 Johnson Conservative government
The Medicines and Healthcare products Regulatory Agency has concluded that Nuvaxovid is safe and effective in this age group
The adapted COVID-19 vaccine made by Moderna targets two different coronavirus variants: the original virus from 2020 and the Omicron variant
As further poliovirus has been detected in sewage, JCVI recommends that polio vaccine booster doses should be offered to children across London.
A joint enforcement notice warns all organisations offering Kenalog as a hayfever treatment to stop advertising it on social media or website advertising
Information about a review into the safety of topiramate, which will look at possible harms in the learning and development of children whose mothers took topiramate during pregnancy.
Officers from the MHRA have seized large quantities of illegally traded medicines and medical devices in an Interpol week of action known as "Operation Pangea"
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).